Back to Avoro Capital Advisors LLC Avoro Capital Advisors LLC

RARERARE
Showing 5 of 15 quarters

Position history for Avoro Capital Advisors LLCAvoro Capital Advisors LLC's holdings in Ultragenyx Pharmaceutical, Inc.

Avoro Capital Advisors LLC previously held 0 shares of RARE (Ultragenyx Pharmaceutical, Inc.), worth $0 as of 2025-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$46.1M

Total Shares Change

-830,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$30.36
0
2025-Q2
Decreased
330,000
-60.2%
$12M0.2%$36.52
0
2025-Q1
Unchanged
830,000
0.0%
$30.1M0.5%$37.82
0
2024-Q4
Unchanged
830,000
0.0%
$34.9M0.5%$42.27
0
2024-Q3
Unchanged
830,000
0.0%
$46.1M0.7%$54.43
0

Other major holders of RARE: Capital Research Global Investors, BNP PARIBAS FINANCIAL MARKETS, Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used